The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man

Millar, J. A. ; McLean, K. A. ; Sumner, D. J. ; Reid, J. L.
Springer
Published 1983
ISSN:
1432-1041
Keywords:
aldosterone ; flurbiprofen ; nifedipine ; blood pressure ; calcium flux ; prostaglandins
Source:
Springer Online Journal Archives 1860-2000
Topics:
Chemistry and Pharmacology
Medicine
Notes:
Summary The effects of the calcium entry blocker nifedipine on blood pressure (BP) and the pressor and aldosterone responses to graded infusions of angiotensin II were studied in normal subjects using 3 protocols. Study 1 was a randomised double-blind placebo-controlled trial of nifedipine (20 mg p.o.) on supine and erect BP in 9 subjects. There was a highly significant fall in BP: (8±4 mmHg; mean±SDM;p〈0.001) with maximum changes occurring 30 min after drug administration. Significant reciprocal changes in pulse rate were observed. These changes were not altered by prior administration of the prostaglandin synthetase inhibitor flurbiprofen (100 mg). In Study 2, 6 subjects were given nifedipine (20 mg) or no treatment mid-way between 2 identical graded infusions of angiotensin II (5, 10 and 20 ng/kg/min) separated by an interval of 1 h on each of 2 study days, and blood pressure and aldosterone responses were measured. There was a significant attenuation of both pressor (p〈0.05) and aldosterone (p〈0.05) responses. The changes in aldosterone responses were not due to changes in plasma renin, potassium or adrenocorticotrophin. In study 3 the pressor and aldosterone responses to angiotensin II (2, 5, 10 and 20 ng/kg/min) were studied after 3 days treatment with nifedipine (20 mg thrice daily) or placebo. Pressor dose response curves to both angiotensin II and noradrenaline were shifted in parallel to the right, but not significantly, and aldosterone responses to angiotensin II were unchanged by nifedipine. These results show that nifedipine may decrease BP in normal subjects by decreasing pressor and aldosterone responses to angiotensin II and that the aldosterone response to angiotensin II in man is possibly calcium-dependent.
Type of Medium:
Electronic Resource
URL:
_version_ 1798295565486784512
autor Millar, J. A.
McLean, K. A.
Sumner, D. J.
Reid, J. L.
autorsonst Millar, J. A.
McLean, K. A.
Sumner, D. J.
Reid, J. L.
book_url http://dx.doi.org/10.1007/BF00610047
datenlieferant nat_lic_papers
hauptsatz hsatz_simple
identnr NLM202438996
issn 1432-1041
journal_name European journal of clinical pharmacology
materialart 1
notes Summary The effects of the calcium entry blocker nifedipine on blood pressure (BP) and the pressor and aldosterone responses to graded infusions of angiotensin II were studied in normal subjects using 3 protocols. Study 1 was a randomised double-blind placebo-controlled trial of nifedipine (20 mg p.o.) on supine and erect BP in 9 subjects. There was a highly significant fall in BP: (8±4 mmHg; mean±SDM;p〈0.001) with maximum changes occurring 30 min after drug administration. Significant reciprocal changes in pulse rate were observed. These changes were not altered by prior administration of the prostaglandin synthetase inhibitor flurbiprofen (100 mg). In Study 2, 6 subjects were given nifedipine (20 mg) or no treatment mid-way between 2 identical graded infusions of angiotensin II (5, 10 and 20 ng/kg/min) separated by an interval of 1 h on each of 2 study days, and blood pressure and aldosterone responses were measured. There was a significant attenuation of both pressor (p〈0.05) and aldosterone (p〈0.05) responses. The changes in aldosterone responses were not due to changes in plasma renin, potassium or adrenocorticotrophin. In study 3 the pressor and aldosterone responses to angiotensin II (2, 5, 10 and 20 ng/kg/min) were studied after 3 days treatment with nifedipine (20 mg thrice daily) or placebo. Pressor dose response curves to both angiotensin II and noradrenaline were shifted in parallel to the right, but not significantly, and aldosterone responses to angiotensin II were unchanged by nifedipine. These results show that nifedipine may decrease BP in normal subjects by decreasing pressor and aldosterone responses to angiotensin II and that the aldosterone response to angiotensin II in man is possibly calcium-dependent.
package_name Springer
publikationsjahr_anzeige 1983
publikationsjahr_facette 1983
publikationsjahr_intervall 8019:1980-1984
publikationsjahr_sort 1983
publisher Springer
reference 24 (1983), S. 315-321
schlagwort aldosterone
flurbiprofen
nifedipine
blood pressure
calcium flux
prostaglandins
search_space articles
shingle_author_1 Millar, J. A.
McLean, K. A.
Sumner, D. J.
Reid, J. L.
shingle_author_2 Millar, J. A.
McLean, K. A.
Sumner, D. J.
Reid, J. L.
shingle_author_3 Millar, J. A.
McLean, K. A.
Sumner, D. J.
Reid, J. L.
shingle_author_4 Millar, J. A.
McLean, K. A.
Sumner, D. J.
Reid, J. L.
shingle_catch_all_1 Millar, J. A.
McLean, K. A.
Sumner, D. J.
Reid, J. L.
The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man
aldosterone
flurbiprofen
nifedipine
blood pressure
calcium flux
prostaglandins
aldosterone
flurbiprofen
nifedipine
blood pressure
calcium flux
prostaglandins
Summary The effects of the calcium entry blocker nifedipine on blood pressure (BP) and the pressor and aldosterone responses to graded infusions of angiotensin II were studied in normal subjects using 3 protocols. Study 1 was a randomised double-blind placebo-controlled trial of nifedipine (20 mg p.o.) on supine and erect BP in 9 subjects. There was a highly significant fall in BP: (8±4 mmHg; mean±SDM;p〈0.001) with maximum changes occurring 30 min after drug administration. Significant reciprocal changes in pulse rate were observed. These changes were not altered by prior administration of the prostaglandin synthetase inhibitor flurbiprofen (100 mg). In Study 2, 6 subjects were given nifedipine (20 mg) or no treatment mid-way between 2 identical graded infusions of angiotensin II (5, 10 and 20 ng/kg/min) separated by an interval of 1 h on each of 2 study days, and blood pressure and aldosterone responses were measured. There was a significant attenuation of both pressor (p〈0.05) and aldosterone (p〈0.05) responses. The changes in aldosterone responses were not due to changes in plasma renin, potassium or adrenocorticotrophin. In study 3 the pressor and aldosterone responses to angiotensin II (2, 5, 10 and 20 ng/kg/min) were studied after 3 days treatment with nifedipine (20 mg thrice daily) or placebo. Pressor dose response curves to both angiotensin II and noradrenaline were shifted in parallel to the right, but not significantly, and aldosterone responses to angiotensin II were unchanged by nifedipine. These results show that nifedipine may decrease BP in normal subjects by decreasing pressor and aldosterone responses to angiotensin II and that the aldosterone response to angiotensin II in man is possibly calcium-dependent.
1432-1041
14321041
Springer
shingle_catch_all_2 Millar, J. A.
McLean, K. A.
Sumner, D. J.
Reid, J. L.
The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man
aldosterone
flurbiprofen
nifedipine
blood pressure
calcium flux
prostaglandins
aldosterone
flurbiprofen
nifedipine
blood pressure
calcium flux
prostaglandins
Summary The effects of the calcium entry blocker nifedipine on blood pressure (BP) and the pressor and aldosterone responses to graded infusions of angiotensin II were studied in normal subjects using 3 protocols. Study 1 was a randomised double-blind placebo-controlled trial of nifedipine (20 mg p.o.) on supine and erect BP in 9 subjects. There was a highly significant fall in BP: (8±4 mmHg; mean±SDM;p〈0.001) with maximum changes occurring 30 min after drug administration. Significant reciprocal changes in pulse rate were observed. These changes were not altered by prior administration of the prostaglandin synthetase inhibitor flurbiprofen (100 mg). In Study 2, 6 subjects were given nifedipine (20 mg) or no treatment mid-way between 2 identical graded infusions of angiotensin II (5, 10 and 20 ng/kg/min) separated by an interval of 1 h on each of 2 study days, and blood pressure and aldosterone responses were measured. There was a significant attenuation of both pressor (p〈0.05) and aldosterone (p〈0.05) responses. The changes in aldosterone responses were not due to changes in plasma renin, potassium or adrenocorticotrophin. In study 3 the pressor and aldosterone responses to angiotensin II (2, 5, 10 and 20 ng/kg/min) were studied after 3 days treatment with nifedipine (20 mg thrice daily) or placebo. Pressor dose response curves to both angiotensin II and noradrenaline were shifted in parallel to the right, but not significantly, and aldosterone responses to angiotensin II were unchanged by nifedipine. These results show that nifedipine may decrease BP in normal subjects by decreasing pressor and aldosterone responses to angiotensin II and that the aldosterone response to angiotensin II in man is possibly calcium-dependent.
1432-1041
14321041
Springer
shingle_catch_all_3 Millar, J. A.
McLean, K. A.
Sumner, D. J.
Reid, J. L.
The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man
aldosterone
flurbiprofen
nifedipine
blood pressure
calcium flux
prostaglandins
aldosterone
flurbiprofen
nifedipine
blood pressure
calcium flux
prostaglandins
Summary The effects of the calcium entry blocker nifedipine on blood pressure (BP) and the pressor and aldosterone responses to graded infusions of angiotensin II were studied in normal subjects using 3 protocols. Study 1 was a randomised double-blind placebo-controlled trial of nifedipine (20 mg p.o.) on supine and erect BP in 9 subjects. There was a highly significant fall in BP: (8±4 mmHg; mean±SDM;p〈0.001) with maximum changes occurring 30 min after drug administration. Significant reciprocal changes in pulse rate were observed. These changes were not altered by prior administration of the prostaglandin synthetase inhibitor flurbiprofen (100 mg). In Study 2, 6 subjects were given nifedipine (20 mg) or no treatment mid-way between 2 identical graded infusions of angiotensin II (5, 10 and 20 ng/kg/min) separated by an interval of 1 h on each of 2 study days, and blood pressure and aldosterone responses were measured. There was a significant attenuation of both pressor (p〈0.05) and aldosterone (p〈0.05) responses. The changes in aldosterone responses were not due to changes in plasma renin, potassium or adrenocorticotrophin. In study 3 the pressor and aldosterone responses to angiotensin II (2, 5, 10 and 20 ng/kg/min) were studied after 3 days treatment with nifedipine (20 mg thrice daily) or placebo. Pressor dose response curves to both angiotensin II and noradrenaline were shifted in parallel to the right, but not significantly, and aldosterone responses to angiotensin II were unchanged by nifedipine. These results show that nifedipine may decrease BP in normal subjects by decreasing pressor and aldosterone responses to angiotensin II and that the aldosterone response to angiotensin II in man is possibly calcium-dependent.
1432-1041
14321041
Springer
shingle_catch_all_4 Millar, J. A.
McLean, K. A.
Sumner, D. J.
Reid, J. L.
The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man
aldosterone
flurbiprofen
nifedipine
blood pressure
calcium flux
prostaglandins
aldosterone
flurbiprofen
nifedipine
blood pressure
calcium flux
prostaglandins
Summary The effects of the calcium entry blocker nifedipine on blood pressure (BP) and the pressor and aldosterone responses to graded infusions of angiotensin II were studied in normal subjects using 3 protocols. Study 1 was a randomised double-blind placebo-controlled trial of nifedipine (20 mg p.o.) on supine and erect BP in 9 subjects. There was a highly significant fall in BP: (8±4 mmHg; mean±SDM;p〈0.001) with maximum changes occurring 30 min after drug administration. Significant reciprocal changes in pulse rate were observed. These changes were not altered by prior administration of the prostaglandin synthetase inhibitor flurbiprofen (100 mg). In Study 2, 6 subjects were given nifedipine (20 mg) or no treatment mid-way between 2 identical graded infusions of angiotensin II (5, 10 and 20 ng/kg/min) separated by an interval of 1 h on each of 2 study days, and blood pressure and aldosterone responses were measured. There was a significant attenuation of both pressor (p〈0.05) and aldosterone (p〈0.05) responses. The changes in aldosterone responses were not due to changes in plasma renin, potassium or adrenocorticotrophin. In study 3 the pressor and aldosterone responses to angiotensin II (2, 5, 10 and 20 ng/kg/min) were studied after 3 days treatment with nifedipine (20 mg thrice daily) or placebo. Pressor dose response curves to both angiotensin II and noradrenaline were shifted in parallel to the right, but not significantly, and aldosterone responses to angiotensin II were unchanged by nifedipine. These results show that nifedipine may decrease BP in normal subjects by decreasing pressor and aldosterone responses to angiotensin II and that the aldosterone response to angiotensin II in man is possibly calcium-dependent.
1432-1041
14321041
Springer
shingle_title_1 The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man
shingle_title_2 The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man
shingle_title_3 The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man
shingle_title_4 The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Springer Online Journal Archives 1860-2000
timestamp 2024-05-06T09:38:13.876Z
titel The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man
titel_suche The effect of the calcium antagonist nifedipine on pressor and aldosterone responses to angiotensin II in normal man
topic V
WW-YZ
uid nat_lic_papers_NLM202438996